ArticleCancer biology & therapy2020

Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.

Xiaohui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.